Diabetes & CV Disease

Sort by:
Relevance Thumbs Up Comments Views Newest Oldest
48:09

Icahn School of Medicine at Mount Sinai

Diagnosis and Treatment of Abnormal Growth: Recommendations and Novel Solutions

FEATURING Cheri Deal
  • 490 views
  • January 4, 2024
  • 4
31:24

Roxana Mehran

Update on Antiplatelet and Antithrombotic Therapy in The Cardiometabolic Patients: Does More Potent Means More Efficacy? Is Increased Risk of Bleeding Associated With ASA Use?

  • 216 views
  • September 22, 2020
  • 2
07:20

Cardiometabolic Health Congress (CMHC)

Cardiometabolic Medicine: Does SGLT2i Improve HFrEF Symptoms, QOL, Reduce the Risk of Hospitalization and CV Mortality? Why Cardiologist Must Intervene in T2D?

FEATURING Keith Ferdinand
  • 103 views
  • January 15, 2021
  • 1
27:04

Peter Rossing

Chronic Kidney Disease in Diabetes: ADA/KDIGO Consensus

  • 1,573 views
  • August 18, 2023
  • 6
18:08

San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

Anti-obesity Therapies and Cardiovascular Disease: No More Breaking My Heart

FEATURING Eduardo Grunvald
  • 957 views
  • March 6, 2024
  • 6
09:44

Stephen D. Wiviott

Update on SGLT2i in Diabetes, CVD & CKD: How Effective Are SGLT2i in Improving Glycemic Control, Cardiovascular & Renal Outcomes?

  • 1,557 views
  • September 11, 2020
  • 5
27:08

Jefferson Health

Inpatient Diabetes Management: An Update

FEATURING Eric Shiffrin
  • 346 views
  • November 23, 2023
  • 3
18:20

Rory Mccrimmon

Habituation & Hypoglycemia: The Value of High Intensity Interval Training in People with Impaired Awareness of Hypoglycemia

  • 218 views
  • October 27, 2023
  • 2
10:36

American College of Cardiology

FIGARO-DKD Trial: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes

FEATURING Valentin Fuster, Dipti Itchhaporia, Michael Mack, Christine Albert, Julia Grapsa
  • 218 views
  • February 15, 2022
  • 2
12:26

Cedars Sinai

Debate: GLP-RA Should Be First Line Therapy for Treatment of Obesity...NOT

FEATURING Kulmeet Sandhu
  • 1,531 views
  • June 4, 2024
  • 6
59:34

Cleveland Clinic - Digestive Disease Institute

Combination Pharmacological Therapy on a Patient with Severe Obesity

FEATURING Maria Magdalena Farias, W. Scott Butsch, Roberto Simons-Linares, Ricard Corcelles
  • 497 views
  • April 23, 2024
  • 3
09:22

CHEST 2024 Insights

CHEST 2024 Insights: The Efficacy of GLP1 Agonists and GIP/GLP1 Co-Agonists on Cardiovascular Outcomes in COPD Patients

FEATURING Xin Ya See
  • 220 views
  • October 28, 2024
  • 2
26:39

Scripps Health

Exercise Is Medicine

FEATURING Karl Nadolsky
  • 1,009 views
  • January 13, 2022
  • 6
20:11

Kidney Week 2023 Insights

Kidney Week 2023 Insights: Ketogenic Metabolic Therapies for CKD

FEATURING Johannes Kovarik
  • 502 views
  • December 18, 2023
  • 4
17:22

Samuel Sherratt

Sotagliflozin, a Dual SGLT 1 and 2 Inhibitor, Has High Membrane Affinity and Hydrocarbon Core Location Compared With Empagliflozin

  • 105 views
  • May 14, 2024
  • 1
10:23

Michigan Medicine - Podiatry

The Effect of Hemodialysis on Diabetic Foot Complications

FEATURING Stephanie Behme, Christopher Girgis, Brian Schmidt
  • 105 views
  • April 10, 2024
  • 1
05:30

NutritionFacts.org

Curing Painful Diabetic Neuropathy

FEATURING Michael Greger
  • 105 views
  • October 3, 2017
  • 1
10:07

Inova Heart and Vascular Institute 2019 Cardiovascular Symposium

The Risk of Living in a Food Desert

FEATURING Javed Butler
  • 221 views
  • May 28, 2019
  • 2
19:12

Practical Ways to Achieve Targets in Diabetes Care

What is the Clinical Relevance of TIR/TAR 70-140 mg/dl for T1D and T2D?

FEATURING Thomas Danne
  • 222 views
  • July 26, 2023
  • 2
32:36

Physicians Committee for Responsible Medicine

2020 Update on Nutrition & Cardiometabolic Health: Which Diet Works Best and Why?

FEATURING Hana Kahleova
  • 1,063 views
  • December 2, 2020
  • 5
30:42

Scripps Health

Diabetes and Renal Disease

FEATURING Christian Mende
  • 708 views
  • November 28, 2022
  • 5
33:09

Simon Heller

ATTD 2023 Insights: What Signifies a Meaningful (Clinical) Reduction in Hypoglycaemia?

  • 354 views
  • April 17, 2023
  • 3
21:28

John Tayek

ADA Standard of Care 2020 Update: What Are the Insulin Therapy Recommendations?

  • 1,072 views
  • January 7, 2021
  • 6
42:33

Jefferson Health

Beyond Glycemic Control: A New Paradigm in T2D Management

FEATURING Intekhab Ahmed
  • 1,073 views
  • December 8, 2023
  • 6
15:40

John Tayek

2020 Updates on ADA Standard of Care: Managing Injectable Therapy and Cardiovascular Risk

  • 1,079 views
  • November 25, 2020
  • 6

Diabetes & CV Disease

All Topics: